Early breast cancer survivors from across the country are about to benefit from the nurse-enabled shared-care model between cancer specialists and general practitioners (GPs) of breast cancer post treatment born out of the Princess Alexandra Hospital thanks to a new trial.
Off the back of the early success of the EMINENT Trial, developed, led and coordinated by PA Hospital/QUT Chair of Cancer Nursing, Professor Ray Chan, a national trial is set to begin this month.
Funded by NHMRC, the IBIS Implementation Trial will utilise the findings from PAH-led EMINENT Trial to implement nurse-enabled, integrated breast cancer post-treatment within seven sites across urban, rural and regional hospitals in four states and territories ensuring optimal care for patients utilising both specialist services and GPs.
“The IBIS Survivorship trial is launching on the 10th May with PAH as one of the recruiting sites.
“The EMINENT trial has demonstrated that a shared-care arrangement between breast cancer specialists and GPs is highly feasible and has a 100% acceptance rate, effectively reducing hospital visits while maintaining optimal cancer care for patients with a broader oversight on comorbidities and other clinical concerns,” said Ray.
The IBIS trial is seeking to reach at least 1350 participants nationally in early breast cancer post treatment.
“Our aim is that this model of care will be adopted and sustained in the real world beyond the completion of this implementation trial.”
“We hope this person-centred, model of care will improve health-related quality of life in a cost-effective manner while enabling cancer specialists to have more time to see newly diagnosed patients.
“With breast cancer diagnosis on the rise, this will enable more people to see specialists with reduced waiting times and faster access to treatment.”